← Open Payments lookup

JENNIFER GODLEY: Open Payments

NPI 1689328197 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,210 in 43 payments from 12 companies in 2025. Trend: 2023 $1,147 · 2024 $1,114 · 2025 $1,210

Food & beverage: $1,205Education: $5
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$236
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$196
Indivior Inc.2$161
Alkermes, Inc.5$154
Otsuka America Pharmaceutical, Inc.5$94
Neurocrine BioSciences, Inc.4$92
E.R. Squibb & Sons, L.L.C.4$86
Vanda Pharmaceuticals Inc.3$57
ABBVIE INC.2$43
Braeburn Inc.2$38

Products named: UZEDY, CAPLYTA, SUBLOCADE, ARISTADA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, FANAPT.

Industry payments across AZ — which companies pay providers there.